{"pmid":32334800,"title":"Surgery during the COVID-19 pandemic: A comprehensive overview and perioperative care.","text":["Surgery during the COVID-19 pandemic: A comprehensive overview and perioperative care.","COVID-19 disease is a pandemic disease caused by a single-stranded RNA virus that belongs to the coronavirus family known as 2019-nCoV (SARS-CoV-2). The disease is highly contagious and transmitted mainly by droplets or close contact. As the global incidence of COVID-19 disease is increasing dramatically, health systems worldwide started to suffer in terms of its capability to manage affected people and the ability to provide standard treatment for critically ill patients in a safe environment. As Medical staff has extensive contact with patients, families as well as other health care providers, they are very likely to cause cross-infection. This paper aims to provide a comprehensive overview of COVID-19 disease as well as to highlight essential measures that healthcare providers and surgeons need to take into consideration during their management of the patient during the COVID-19 pandemic.","Am J Surg","Al-Balas, Mahmoud","Al-Balas, Hasan Ibrahim","Al-Balas, Hamzeh","32334800"],"abstract":["COVID-19 disease is a pandemic disease caused by a single-stranded RNA virus that belongs to the coronavirus family known as 2019-nCoV (SARS-CoV-2). The disease is highly contagious and transmitted mainly by droplets or close contact. As the global incidence of COVID-19 disease is increasing dramatically, health systems worldwide started to suffer in terms of its capability to manage affected people and the ability to provide standard treatment for critically ill patients in a safe environment. As Medical staff has extensive contact with patients, families as well as other health care providers, they are very likely to cause cross-infection. This paper aims to provide a comprehensive overview of COVID-19 disease as well as to highlight essential measures that healthcare providers and surgeons need to take into consideration during their management of the patient during the COVID-19 pandemic."],"journal":"Am J Surg","authors":["Al-Balas, Mahmoud","Al-Balas, Hasan Ibrahim","Al-Balas, Hamzeh"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32334800","week":"202018|Apr 27 - May 03","doi":"10.1016/j.amjsurg.2020.04.018","keywords":["covid-19","coronavirus family","perioperative measures"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1665172301934493696,"score":8.518259,"similar":[{"pmid":32195698,"pmcid":"PMC7155909","title":"COVID-19 Infection: Implications for Perioperative and Critical Care Physicians.","text":["COVID-19 Infection: Implications for Perioperative and Critical Care Physicians.","Healthcare systems worldwide are responding to Coronavirus Disease 2019 (COVID-19), an emerging infectious syndrome caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. Patients with COVID-19 can progress from asymptomatic or mild illness to hypoxemic respiratory failure or multisystem organ failure, necessitating intubation and intensive care management. Healthcare providers, and particularly anesthesiologists, are at the frontline of this epidemic, and they need to be aware of the best available evidence to guide therapeutic management of patients with COVID-19 and to keep themselves safe while doing so. Here, the authors review COVID-19 pathogenesis, presentation, diagnosis, and potential therapeutics, with a focus on management of COVID-19-associated respiratory failure. The authors draw on literature from other viral epidemics, treatment of acute respiratory distress syndrome, and recent publications on COVID-19, as well as guidelines from major health organizations. This review provides a comprehensive summary of the evidence currently available to guide management of critically ill patients with COVID-19.","Anesthesiology","Greenland, John R","Michelow, Marilyn D","Wang, Linlin","London, Martin J","32195698"],"abstract":["Healthcare systems worldwide are responding to Coronavirus Disease 2019 (COVID-19), an emerging infectious syndrome caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. Patients with COVID-19 can progress from asymptomatic or mild illness to hypoxemic respiratory failure or multisystem organ failure, necessitating intubation and intensive care management. Healthcare providers, and particularly anesthesiologists, are at the frontline of this epidemic, and they need to be aware of the best available evidence to guide therapeutic management of patients with COVID-19 and to keep themselves safe while doing so. Here, the authors review COVID-19 pathogenesis, presentation, diagnosis, and potential therapeutics, with a focus on management of COVID-19-associated respiratory failure. The authors draw on literature from other viral epidemics, treatment of acute respiratory distress syndrome, and recent publications on COVID-19, as well as guidelines from major health organizations. This review provides a comprehensive summary of the evidence currently available to guide management of critically ill patients with COVID-19."],"journal":"Anesthesiology","authors":["Greenland, John R","Michelow, Marilyn D","Wang, Linlin","London, Martin J"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32195698","week":"202012|Mar 16 - Mar 22","doi":"10.1097/ALN.0000000000003303","source":"PubMed","topics":["Mechanism","Diagnosis","Treatment"],"weight":1,"_version_":1664640930694561794,"score":208.7111},{"pmid":32320516,"title":"Scientific research progress of COVID-19/ SARS-CoV-2 in the first five months.","text":["Scientific research progress of COVID-19/ SARS-CoV-2 in the first five months.","A cluster of pneumonia (COVID-19) cases have been found in Wuhan China in late December, 2019 and subsequently a novel coronavirus with a positive stranded RNA was identified to be the etiological virus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2), which has a phylogenetic similarity to severe acute respiratory syndrome coronavirus (SARS-CoV). SARS-CoV-2 transmits mainly through droplets and close contact and the elder or people with chronic diseases are high-risk population. People affected by SARS-CoV-2 can be asymptomatic, which brings about more difficulties to control the transmission. COVID-19 has become pandemic rapidly after onset and so far the infected people have been above 2,000,000 and more than 130,000 died worldwide according to COVID-19 situation dashboard of World Health Organization (https://covid19.who.int). Here, we summarized the current known knowledge regarding epidemiological, pathogenesis, pathology, clinical features, comorbidities and treatment of COVID-19/ SARS-CoV-2 as reference for the prevention and control COVID-19.","J Cell Mol Med","Li, Hua","Liu, Zhe","Ge, Junbo","32320516"],"abstract":["A cluster of pneumonia (COVID-19) cases have been found in Wuhan China in late December, 2019 and subsequently a novel coronavirus with a positive stranded RNA was identified to be the etiological virus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2), which has a phylogenetic similarity to severe acute respiratory syndrome coronavirus (SARS-CoV). SARS-CoV-2 transmits mainly through droplets and close contact and the elder or people with chronic diseases are high-risk population. People affected by SARS-CoV-2 can be asymptomatic, which brings about more difficulties to control the transmission. COVID-19 has become pandemic rapidly after onset and so far the infected people have been above 2,000,000 and more than 130,000 died worldwide according to COVID-19 situation dashboard of World Health Organization (https://covid19.who.int). Here, we summarized the current known knowledge regarding epidemiological, pathogenesis, pathology, clinical features, comorbidities and treatment of COVID-19/ SARS-CoV-2 as reference for the prevention and control COVID-19."],"journal":"J Cell Mol Med","authors":["Li, Hua","Liu, Zhe","Ge, Junbo"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32320516","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jcmm.15364","source":"PubMed","topics":["Mechanism","Treatment","Diagnosis","Prevention"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664815087620194304,"score":187.3757},{"pmid":32276778,"pmcid":"PMC7141547","title":"Caring for the carers: Ensuring the provision of quality maternity care during a global pandemic.","text":["Caring for the carers: Ensuring the provision of quality maternity care during a global pandemic.","The COVID-19 pandemic is impacting health systems worldwide. Maternity care providers must continue their core business in caring and supporting women, newborns and their families whilst also adapting to a rapidly changing health system environment. This article provides an overview of important considerations for supporting the emotional, mental and physical health needs of maternity care providers in the context of the unprecedented crisis that COVID-19 presents. Cooperation, planning ahead and adequate availability of PPE is critical. Thinking about the needs of maternity providers to prevent stress and burnout is essential. Emotional and psychological support needs to be available throughout the response. Prioritising food, rest and exercise are important. Healthcare workers are every country's most valuable resource and maternity providers need to be supported to provide the best quality care they can to women and newborns in exceptionally trying circumstances.","Women Birth","Wilson, Alyce N","Ravaldi, Claudia","Scoullar, Michelle J L","Vogel, Joshua P","Szabo, Rebecca A","Fisher, Jane R W","Homer, Caroline S E","32276778"],"abstract":["The COVID-19 pandemic is impacting health systems worldwide. Maternity care providers must continue their core business in caring and supporting women, newborns and their families whilst also adapting to a rapidly changing health system environment. This article provides an overview of important considerations for supporting the emotional, mental and physical health needs of maternity care providers in the context of the unprecedented crisis that COVID-19 presents. Cooperation, planning ahead and adequate availability of PPE is critical. Thinking about the needs of maternity providers to prevent stress and burnout is essential. Emotional and psychological support needs to be available throughout the response. Prioritising food, rest and exercise are important. Healthcare workers are every country's most valuable resource and maternity providers need to be supported to provide the best quality care they can to women and newborns in exceptionally trying circumstances."],"journal":"Women Birth","authors":["Wilson, Alyce N","Ravaldi, Claudia","Scoullar, Michelle J L","Vogel, Joshua P","Szabo, Rebecca A","Fisher, Jane R W","Homer, Caroline S E"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32276778","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.wombi.2020.03.011","keywords":["covid-19","emotional and psychological support","maternity care providers","maternity services","pandemic preparedness"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664636943996026880,"score":186.0188},{"pmid":32265065,"pmcid":"PMC7102516","title":"Coronavirus Disease (COVID-19): A primer for emergency physicians.","text":["Coronavirus Disease (COVID-19): A primer for emergency physicians.","INTRODUCTION: Rapid worldwide spread of Coronavirus Disease 2019 (COVID-19) has resulted in a global pandemic. OBJECTIVE: This review article provides emergency physicians with an overview of the most current understanding of COVID-19 and recommendations on the evaluation and management of patients with suspected COVID-19. DISCUSSION: Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for causing COVID-19, is primarily transmitted from person-to-person through close contact (approximately 6 ft) by respiratory droplets. Symptoms of COVID-19 are similar to other viral upper respiratory illnesses. Three major trajectories include mild disease with upper respiratory symptoms, non-severe pneumonia, and severe pneumonia complicated by acute respiratory distress syndrome (ARDS). Emergency physicians should focus on identifying patients at risk, isolating suspected patients, and informing hospital infection prevention and public health authorities. Patients with suspected COVID-19 should be asked to wear a facemask. Respiratory etiquette, hand washing, and personal protective equipment are recommended for all healthcare personnel caring for suspected cases. Disposition depends on patient symptoms, hemodynamic status, and patient ability to self-quarantine. CONCLUSION: This narrative review provides clinicians with an updated approach to the evaluation and management of patients presenting to the emergency department with suspected COVID-19.","Am J Emerg Med","Chavez, Summer","Long, Brit","Koyfman, Alex","Liang, Stephen Y","32265065"],"abstract":["INTRODUCTION: Rapid worldwide spread of Coronavirus Disease 2019 (COVID-19) has resulted in a global pandemic. OBJECTIVE: This review article provides emergency physicians with an overview of the most current understanding of COVID-19 and recommendations on the evaluation and management of patients with suspected COVID-19. DISCUSSION: Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for causing COVID-19, is primarily transmitted from person-to-person through close contact (approximately 6 ft) by respiratory droplets. Symptoms of COVID-19 are similar to other viral upper respiratory illnesses. Three major trajectories include mild disease with upper respiratory symptoms, non-severe pneumonia, and severe pneumonia complicated by acute respiratory distress syndrome (ARDS). Emergency physicians should focus on identifying patients at risk, isolating suspected patients, and informing hospital infection prevention and public health authorities. Patients with suspected COVID-19 should be asked to wear a facemask. Respiratory etiquette, hand washing, and personal protective equipment are recommended for all healthcare personnel caring for suspected cases. Disposition depends on patient symptoms, hemodynamic status, and patient ability to self-quarantine. CONCLUSION: This narrative review provides clinicians with an updated approach to the evaluation and management of patients presenting to the emergency department with suspected COVID-19."],"journal":"Am J Emerg Med","authors":["Chavez, Summer","Long, Brit","Koyfman, Alex","Liang, Stephen Y"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32265065","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.ajem.2020.03.036","keywords":["covid-19","coronavirus disease","infectious disease","pulmonary"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664637635973349377,"score":181.59308},{"pmid":32310621,"title":"Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children.","text":["Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children.","Coronaviruses (CoVs) are a large family of enveloped, single-stranded, zoonotic RNA viruses. Four CoVs commonly circulate among humans: HCoV2-229E, -HKU1, -NL63 and -OC43. However, CoVs can rapidly mutate and recombine leading to novel CoVs that can spread from animals to humans. The novel CoVs severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in 2002 and Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012. The 2019 novel coronavirus (SARS-CoV-2) is currently causing a severe outbreak of disease (termed COVID-19) in China and multiple other countries, threatening to cause a global pandemic. In humans, CoVs mostly cause respiratory and gastrointestinal symptoms. Clinical manifestations range from a common cold to more severe disease such as bronchitis, pneumonia, severe acute respiratory distress syndrome, multi-organ failure and even death. SARS-CoV, MERS-CoV and SARS-CoV-2 seem to less commonly affect children and to cause fewer symptoms and less severe disease in this age group compared with adults, and are associated with much lower case-fatality rates. Preliminary evidence suggests children are just as likely as adults to become infected with SARS-CoV-2 but are less likely to be symptomatic or develop severe symptoms. However, the importance of children in transmitting the virus remains uncertain. Children more often have gastrointestinal symptoms compared with adults. Most children with SARS-CoV present with fever, but this is not the case for the other novel CoVs. Many children affected by MERS-CoV are asymptomatic. The majority of children infected by novel CoVs have a documented household contact, often showing symptoms before them. In contrast, adults more often have a nosocomial exposure. In this review, we summarize epidemiologic, clinical and diagnostic findings, as well as treatment and prevention options for common circulating and novel CoVs infections in humans with a focus on infections in children.","Pediatr Infect Dis J","Zimmermann, Petra","Curtis, Nigel","32310621"],"abstract":["Coronaviruses (CoVs) are a large family of enveloped, single-stranded, zoonotic RNA viruses. Four CoVs commonly circulate among humans: HCoV2-229E, -HKU1, -NL63 and -OC43. However, CoVs can rapidly mutate and recombine leading to novel CoVs that can spread from animals to humans. The novel CoVs severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in 2002 and Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012. The 2019 novel coronavirus (SARS-CoV-2) is currently causing a severe outbreak of disease (termed COVID-19) in China and multiple other countries, threatening to cause a global pandemic. In humans, CoVs mostly cause respiratory and gastrointestinal symptoms. Clinical manifestations range from a common cold to more severe disease such as bronchitis, pneumonia, severe acute respiratory distress syndrome, multi-organ failure and even death. SARS-CoV, MERS-CoV and SARS-CoV-2 seem to less commonly affect children and to cause fewer symptoms and less severe disease in this age group compared with adults, and are associated with much lower case-fatality rates. Preliminary evidence suggests children are just as likely as adults to become infected with SARS-CoV-2 but are less likely to be symptomatic or develop severe symptoms. However, the importance of children in transmitting the virus remains uncertain. Children more often have gastrointestinal symptoms compared with adults. Most children with SARS-CoV present with fever, but this is not the case for the other novel CoVs. Many children affected by MERS-CoV are asymptomatic. The majority of children infected by novel CoVs have a documented household contact, often showing symptoms before them. In contrast, adults more often have a nosocomial exposure. In this review, we summarize epidemiologic, clinical and diagnostic findings, as well as treatment and prevention options for common circulating and novel CoVs infections in humans with a focus on infections in children."],"journal":"Pediatr Infect Dis J","authors":["Zimmermann, Petra","Curtis, Nigel"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32310621","week":"202017|Apr 20 - Apr 26","doi":"10.1097/INF.0000000000002660","source":"PubMed","topics":["Treatment","Diagnosis","Prevention"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664632501365112832,"score":178.90253}]}